Investors with a lot of money to spend have taken a bullish stance on Johnson & Johnson (NYSE:JNJ).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with JNJ, it often means somebody knows something is about to happen.So how do we know what these investors just did? Today, Benzinga's options scanner sp ...

Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE: JNJ) revealed 17 unusual trades.Delving into the details, we found 58% of traders were bullish, while 23% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $283,763, and 14 were calls, valued at $935,177.Projected Price TargetsAnalyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a ...

Let's get a Wednesday edition of Kramer's Mad Dash. The best non-bank is J&J. I mean, this J&J quarter, it may set, you know, they're not talking that much about tariffs.Uh, that is going to happen. They're probably a later thing. But I was stunned.The oncology sales are incredible, up 24%. They have new bladder cancer. Uh, I nothing's a cure, but great maintenance that I think uh medtech finally came back.It was really sensational. Uh, a lot of people were thinking that medtech was weaker. uh neuroscience ...